Back to Authors

Jonsson, Ann-Beth

Mayo Clinic

Karolinska Institutet

Citations 1

CD46 in Meningococcal Disease
Johansson, Linda , Rytkönen, Anne, Bergman, Peter , Albiger, Barbara , Källström, Helena, Hökfelt, Tomas , Agerberth, Birgitta, Cattaneo, Roberto , Jonsson, Ann-Beth

Science | July 17, 2003 | Volume: 301 | Issue: 5631 | Pages: 373-375

10.1126/science.1086476 Get It

The human-specific bacterial pathogen Neisseria meningitidis is a major cause of sepsis and/or meningitis. The pili of N. meningitidis interact with CD46, a human cell-surface protein involved in regulation of complement activation. Transgenic mice expressing human CD46 were susceptible to meningococcal disease, because bacteria crossed the blood-brain barrier in these mice. Development of disease was more efficient with piliated bacteria after intranasal, but not intraperitoneal, challenge of CD46 transgenic mice, suggesting that human CD46 facilitates pilus-dependent interactions at the epithelial mucosa. Hence, the human CD46 transgenic mice model is a potentially useful tool for studying pathogenesis and for vaccine development against meningococcal disease.